Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study

Background and aims: Due to its involvement in tumor biology as well as tumor-associated stroma cell responses, recent data suggested a potential role of miR-29 as a biomarker for different malignancies. However, its role in neuroendocrine tumors (NETs) is only poorly understood. Methods: We measure...

Full description

Bibliographic Details
Main Authors: Burcin Özdirik, Anna K. Stueven, Raphael Mohr, Lukas Geisler, Alexander Wree, Jana Knorr, Münevver Demir, Mihael Vucur, Sven H. Loosen, Fabian Benz, Markus Reiss, Bertram Wiedenmann, Frank Tacke, Henning Jann, Teresa Hellberg, Christoph Roderburg
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
miR-29
neuroendocrine tumor
neuroendocrine carcinoma
biomarker
survival
Online Access:https://www.mdpi.com/2077-0383/9/9/2881

Internet

https://www.mdpi.com/2077-0383/9/9/2881

Similar Items